ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
62 986,07
-1,18%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. bluebird bio Inc (BLUE)

  7. bluebird bio Inc (BLUE) Actualités

BLUE bluebird bio Inc

0,9399
0,0274 (3,00%)
27 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
bluebird bio Inc BLUE NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,0274 3,00% 0,9399 01:40:57
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,9102 0,893 0,9458 0,9228 0,9125
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
26/4/202422:05BWbluebird bio Announces Receipt of Expected Notice from..
26/4/202411:45PRNUSBLUE LAWSUIT ALERT: The Gross Law Firm Notifies bluebird..
19/4/202411:45PRNUSbluebird bio, Inc. Sued for Securities Law Violations -..
16/4/202411:45PRNUSClass Action Filed Against bluebird bio, Inc. (BLUE) Seeking..
12/4/202411:45PRNUSShareholders that lost money on bluebird bio, Inc.(BLUE)..
11/4/202414:00BWbluebird bio Reports Inducement Grants Under Nasdaq Listing..
09/4/202411:45PRNUSbluebird bio, Inc. Sued for Securities Law Violations -..
05/4/202411:45PRNUSShareholders that lost money on bluebird bio, Inc.(BLUE)..
26/3/202412:01BWbluebird bio Reports Fourth Quarter and 2023 Annual Results..
25/3/202421:05BWbluebird bio to Host Fourth Quarter and 2023 Annual Results..
18/3/202413:00BWbluebird bio Secures up to $175 Million Debt Financing with..
11/3/202413:00BWbluebird bio Announces First Outcomes-Based Agreement with..
05/3/202423:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202419:54EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202414:03EDGAR2Form 8-K - Current report
08/1/202414:00BWbluebird bio Provides Update on Commercial Launch Progress,..
04/1/202414:00EDGAR2Form 8-K - Current report
02/1/202414:00BWbluebird bio to Present at the 42nd Annual J.P. Morgan..
20/12/202323:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/12/202313:42EDGAR2Form 8-K - Current report
20/12/202303:41BWbluebird bio, Inc. Announces Pricing of $125 Million Public..
19/12/202312:10IHMARKETNEWSGoogle $700M Antitrust Settlement, TSMC Chairman Retirement,..
18/12/202323:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/12/202322:48EDGAR2Form 8-K - Current report
18/12/202322:01BWbluebird bio, Inc. Announces Proposed Public Offering of..
14/12/202313:30EDGAR2Form 8-K - Current report
11/12/202314:06EDGAR2Form 8-K - Current report
10/12/202318:02BWLong-Term Data Presented at ASH Support beti-cel as a..
09/12/202317:31BWLong-term Follow-up Data From bluebird’s Gene Therapy..
08/12/202322:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202322:11DJNBluebird Bio Shares Slide 41% on Black-Box Label, Higher..
08/12/202319:01BWbluebird bio Details Plans for the Commercial Launch of..
08/12/202318:35BWbluebird bio Announces FDA Approval of LYFGENIA™..
08/12/202318:03DJNBluebird Bio Gets FDA OK of Lyfgenia Gene Therapy in..
07/11/202313:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:01EDGAR2Form 8-K - Current report
07/11/202313:00BWbluebird bio Reports Third Quarter 2023 Financial Results..
03/11/202321:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202321:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202314:37BWbluebird bio to Present New and Updated Data from Gene..

Dernières Valeurs Consultées

NASDAQ
BLUE
bluebird bio
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés